Optimal anesthetic regimen for ambulatory laser microlaryngeal surgery

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives/Hypothesis: Laser microlaryngeal surgery (LMS) is a short operation requiring brief and intense paralysis. Adequate muscle relaxation and rapid recovery of neuromuscular function are essential for improving surgical conditions and reducing the incidence of complications during LMS. However, the ideal muscle relaxant with a rapid onset and short duration of action is not yet available. Rocuronium has rapid onset at higher doses, but with a prolonged duration of action. Sugammadex is a selective relaxant-binding agent that allows for rapid reversal of rocuronium-induced neuromuscular blockade. This study aimed to compare the surgical conditions and anesthesia time between two combinations of neuromuscular blocker and reversal agent, rocuronium-sugammadex (R-S) and succinylcholine-cisatracurium-pyridostigmine (S-C-P), and propose an optimal anesthetic regimen for improving the surgical conditions in LMS patients. Study Design: Prospective, randomized, double-blinded clinical study. Methods: Patients in the R-S group received 1 mg/kg rocuronium bromide, whereas those in the S-C-P group received 1 mg/kg succinylcholine. After endotracheal intubation, 0.08 mg/kg cisatracurium was injected in S-C-P patients. After the procedure, R-S patients received 2 mg/kg sugammedex, whereas S-C-P patients received 0.2 mg/kg pyridostigmine plus 10 μg/kg atropine. Results: In the R-S group, surgical condition scores were significantly higher and anesthesia time was significantly shorter. The use of additive neuromuscular blocking agents was significantly higher in the S-C-P group. Conclusions: Muscle relaxation with rocuronium and reversal with sugammadex resulted in better surgical conditions and a shorter anesthesia time in patients undergoing LMS when compared to the S-C-P regimen. Level of Evidence: 1b Laryngoscope, 127:1135–1139, 2017.

Original languageEnglish
Pages (from-to)1135-1139
Number of pages5
JournalLaryngoscope
Volume127
Issue number5
DOIs
Publication statusPublished - 2017 May 1

Fingerprint

Pyridostigmine Bromide
Laser Therapy
Succinylcholine
Anesthetics
Neuromuscular Blocking Agents
Muscle Relaxation
Anesthesia
Laryngoscopes
Neuromuscular Blockade
Intratracheal Intubation
rocuronium
Recovery of Function
cisatracurium
Atropine
Paralysis
Sugammadex
Prospective Studies
Muscles
Incidence

Keywords

  • Laser microlaryngeal surgery
  • rocuronium
  • succinylcholine
  • sugammadex
  • surgical condition

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Optimal anesthetic regimen for ambulatory laser microlaryngeal surgery. / Huh, Hyub; Park, Seol Ju; Lim, Hyong Hwan; Jung, Kwang-Yoon; Baek, Seung-Kuk; Yoon, Seung-Zhoo; Lee, Hye Won; Lim, Hae Ja; Cho, Jang-Eun.

In: Laryngoscope, Vol. 127, No. 5, 01.05.2017, p. 1135-1139.

Research output: Contribution to journalArticle

@article{620e481b5f144575b60050cf2288f710,
title = "Optimal anesthetic regimen for ambulatory laser microlaryngeal surgery",
abstract = "Objectives/Hypothesis: Laser microlaryngeal surgery (LMS) is a short operation requiring brief and intense paralysis. Adequate muscle relaxation and rapid recovery of neuromuscular function are essential for improving surgical conditions and reducing the incidence of complications during LMS. However, the ideal muscle relaxant with a rapid onset and short duration of action is not yet available. Rocuronium has rapid onset at higher doses, but with a prolonged duration of action. Sugammadex is a selective relaxant-binding agent that allows for rapid reversal of rocuronium-induced neuromuscular blockade. This study aimed to compare the surgical conditions and anesthesia time between two combinations of neuromuscular blocker and reversal agent, rocuronium-sugammadex (R-S) and succinylcholine-cisatracurium-pyridostigmine (S-C-P), and propose an optimal anesthetic regimen for improving the surgical conditions in LMS patients. Study Design: Prospective, randomized, double-blinded clinical study. Methods: Patients in the R-S group received 1 mg/kg rocuronium bromide, whereas those in the S-C-P group received 1 mg/kg succinylcholine. After endotracheal intubation, 0.08 mg/kg cisatracurium was injected in S-C-P patients. After the procedure, R-S patients received 2 mg/kg sugammedex, whereas S-C-P patients received 0.2 mg/kg pyridostigmine plus 10 μg/kg atropine. Results: In the R-S group, surgical condition scores were significantly higher and anesthesia time was significantly shorter. The use of additive neuromuscular blocking agents was significantly higher in the S-C-P group. Conclusions: Muscle relaxation with rocuronium and reversal with sugammadex resulted in better surgical conditions and a shorter anesthesia time in patients undergoing LMS when compared to the S-C-P regimen. Level of Evidence: 1b Laryngoscope, 127:1135–1139, 2017.",
keywords = "Laser microlaryngeal surgery, rocuronium, succinylcholine, sugammadex, surgical condition",
author = "Hyub Huh and Park, {Seol Ju} and Lim, {Hyong Hwan} and Kwang-Yoon Jung and Seung-Kuk Baek and Seung-Zhoo Yoon and Lee, {Hye Won} and Lim, {Hae Ja} and Jang-Eun Cho",
year = "2017",
month = "5",
day = "1",
doi = "10.1002/lary.26368",
language = "English",
volume = "127",
pages = "1135--1139",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Optimal anesthetic regimen for ambulatory laser microlaryngeal surgery

AU - Huh, Hyub

AU - Park, Seol Ju

AU - Lim, Hyong Hwan

AU - Jung, Kwang-Yoon

AU - Baek, Seung-Kuk

AU - Yoon, Seung-Zhoo

AU - Lee, Hye Won

AU - Lim, Hae Ja

AU - Cho, Jang-Eun

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Objectives/Hypothesis: Laser microlaryngeal surgery (LMS) is a short operation requiring brief and intense paralysis. Adequate muscle relaxation and rapid recovery of neuromuscular function are essential for improving surgical conditions and reducing the incidence of complications during LMS. However, the ideal muscle relaxant with a rapid onset and short duration of action is not yet available. Rocuronium has rapid onset at higher doses, but with a prolonged duration of action. Sugammadex is a selective relaxant-binding agent that allows for rapid reversal of rocuronium-induced neuromuscular blockade. This study aimed to compare the surgical conditions and anesthesia time between two combinations of neuromuscular blocker and reversal agent, rocuronium-sugammadex (R-S) and succinylcholine-cisatracurium-pyridostigmine (S-C-P), and propose an optimal anesthetic regimen for improving the surgical conditions in LMS patients. Study Design: Prospective, randomized, double-blinded clinical study. Methods: Patients in the R-S group received 1 mg/kg rocuronium bromide, whereas those in the S-C-P group received 1 mg/kg succinylcholine. After endotracheal intubation, 0.08 mg/kg cisatracurium was injected in S-C-P patients. After the procedure, R-S patients received 2 mg/kg sugammedex, whereas S-C-P patients received 0.2 mg/kg pyridostigmine plus 10 μg/kg atropine. Results: In the R-S group, surgical condition scores were significantly higher and anesthesia time was significantly shorter. The use of additive neuromuscular blocking agents was significantly higher in the S-C-P group. Conclusions: Muscle relaxation with rocuronium and reversal with sugammadex resulted in better surgical conditions and a shorter anesthesia time in patients undergoing LMS when compared to the S-C-P regimen. Level of Evidence: 1b Laryngoscope, 127:1135–1139, 2017.

AB - Objectives/Hypothesis: Laser microlaryngeal surgery (LMS) is a short operation requiring brief and intense paralysis. Adequate muscle relaxation and rapid recovery of neuromuscular function are essential for improving surgical conditions and reducing the incidence of complications during LMS. However, the ideal muscle relaxant with a rapid onset and short duration of action is not yet available. Rocuronium has rapid onset at higher doses, but with a prolonged duration of action. Sugammadex is a selective relaxant-binding agent that allows for rapid reversal of rocuronium-induced neuromuscular blockade. This study aimed to compare the surgical conditions and anesthesia time between two combinations of neuromuscular blocker and reversal agent, rocuronium-sugammadex (R-S) and succinylcholine-cisatracurium-pyridostigmine (S-C-P), and propose an optimal anesthetic regimen for improving the surgical conditions in LMS patients. Study Design: Prospective, randomized, double-blinded clinical study. Methods: Patients in the R-S group received 1 mg/kg rocuronium bromide, whereas those in the S-C-P group received 1 mg/kg succinylcholine. After endotracheal intubation, 0.08 mg/kg cisatracurium was injected in S-C-P patients. After the procedure, R-S patients received 2 mg/kg sugammedex, whereas S-C-P patients received 0.2 mg/kg pyridostigmine plus 10 μg/kg atropine. Results: In the R-S group, surgical condition scores were significantly higher and anesthesia time was significantly shorter. The use of additive neuromuscular blocking agents was significantly higher in the S-C-P group. Conclusions: Muscle relaxation with rocuronium and reversal with sugammadex resulted in better surgical conditions and a shorter anesthesia time in patients undergoing LMS when compared to the S-C-P regimen. Level of Evidence: 1b Laryngoscope, 127:1135–1139, 2017.

KW - Laser microlaryngeal surgery

KW - rocuronium

KW - succinylcholine

KW - sugammadex

KW - surgical condition

UR - http://www.scopus.com/inward/record.url?scp=84999752046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84999752046&partnerID=8YFLogxK

U2 - 10.1002/lary.26368

DO - 10.1002/lary.26368

M3 - Article

C2 - 27796041

AN - SCOPUS:84999752046

VL - 127

SP - 1135

EP - 1139

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 5

ER -